Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia

References

• Andrade AG, Bubu OM, Varga AW, et al. The relationship between obstructive sleep apnea and Alzheimer’s disease. J Alzheimers Dis. 2018;64(s1):S255–S270. doi:10.3233/JAD-179936
   PubMed Web of Science ®Google Scholar
• Xu L, Li Q, Ke Y, et al. Chronic intermittent hypoxia-induced aberrant neural activities in the hippocampus of male rats revealed by long-term in vivo recording. Front Cell Neurosci. 2021;15:784045. doi:10.3389/fncel.2021.784045
   PubMed Web of Science ®Google Scholar
• Gagnon K, Baril -A-A, Gagnon J-F, et al. Cognitive impairment in obstructive sleep apnea. Pathol Biol. 2014;62(5):233–240. doi:10.1016/j.patbio.2014.05.015
   PubMedGoogle Scholar
• Zhao YS, Tan M, Song J-X, et al. Involvement of hepcidin in cognitive damage induced by chronic intermittent hypoxia in mice. Oxid Med Cell Longev. 2021;2021:8520967. doi:10.1155/2021/8520967
   PubMed Web of Science ®Google Scholar
• Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–698. doi:10.1016/S2213-2600(19)30198-5
   PubMed Web of Science ®Google Scholar
• Lee W, Nagubadi S, Kryger MH, et al. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med. 2008;2(3):349–364. doi:10.1586/17476348.2.3.349
   PubMedGoogle Scholar
• Rosenzweig I, Glasser M, Polsek D, et al. Sleep apnoea and the brain: a complex relationship. Lancet Respir Med. 2015;3(5):404–414. doi:10.1016/S2213-2600(15)00090-9
   PubMed Web of Science ®Google Scholar
• Xu LH, Xie H, Shi Z-H, et al. Critical role of endoplasmic reticulum stress in chronic intermittent hypoxia-induced deficits in synaptic plasticity and long-term memory. Antioxid Redox Signal. 2015;23(9):695–710. doi:10.1089/ars.2014.6122
   PubMed Web of Science ®Google Scholar
• Khuu MA, Pagan CM, Nallamothu T, et al. Intermittent hypoxia disrupts adult neurogenesis and synaptic plasticity in the dentate gyrus. J Neurosci. 2019;39(7):1320–1331. doi:10.1523/JNEUROSCI.1359-18.2018
   PubMed Web of Science ®Google Scholar
• Shiota S, Takekawa H, Matsumoto S-E, et al. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-beta generation in mice. J Alzheimers Dis. 2013;37(2):325–333. doi:10.3233/JAD-130419
   PubMed Web of Science ®Google Scholar
• Marciante AB, Howard J, Kelly MN, et al. Dose-dependent phosphorylation of endogenous Tau by intermittent hypoxia in rat brain. J Appl Physiol. 2022;133(3):561–571. doi:10.1152/japplphysiol.00332.2022
   PubMed Web of Science ®Google Scholar
• Kazim SF, Sharma A, Saroja SR, et al. Chronic intermittent hypoxia enhances pathological tau seeding, propagation, and accumulation and exacerbates Alzheimer-like memory and synaptic plasticity deficits and molecular signatures. Biol Psychiatry. 2022;91(4):346–358. doi:10.1016/j.biopsych.2021.02.973
   PubMed Web of Science ®Google Scholar
• Wang J, Xu Z, Xu L, et al. Inhibition of STAT3 signal pathway recovers postsynaptic plasticity to improve cognitive impairment caused by chronic intermittent hypoxia. Sleep Breath. 2022. doi:10.1007/s11325-022-02671-6
   Web of Science ®Google Scholar
• Wall AM, Corcoran AE, O’Halloran KD, et al. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus. Neurobiol Dis. 2014;62:8–17. doi:10.1016/j.nbd.2013.08.016
   PubMed Web of Science ®Google Scholar
• Zhao YS, An J-R, Yang S, et al. Hydrogen and oxygen mixture to improve cardiac dysfunction and myocardial pathological changes induced by intermittent hypoxia in rats. Oxid Med Cell Longev. 2019;2019:7415212. doi:10.1155/2019/7415212
   PubMed Web of Science ®Google Scholar
• An JR, Zhao Y-S, Luo L-F, et al. Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia. Life Sci. 2020;250:117573. doi:10.1016/j.lfs.2020.117573
   PubMed Web of Science ®Google Scholar
• Wang P, Cui Y, Ren Q, et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis. Cell Death Dis. 2021;12(5):447. doi:10.1038/s41419-021-03725-5
   PubMed Web of Science ®Google Scholar
• You L, Yu -P-P, Dong T, et al. Astrocyte-derived hepcidin controls iron traffic at the blood-brain-barrier via regulating ferroportin 1 of microvascular endothelial cells. Cell Death Dis. 2022;13(8):667. doi:10.1038/s41419-022-05043-w
   PubMed Web of Science ®Google Scholar
• You LH, Yan C-Z, Zheng B-J, et al. Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis. 2017;8(3):e2676. doi:10.1038/cddis.2017.93
   PubMedGoogle Scholar
• Kwan P, Ho A, Baum L. Effects of deferasirox in Alzheimer’s disease and tauopathy animal models. Biomolecules. 2022;12(3):365 doi:10.3390/biom12030365.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Zheng CY, Yan H, et al. Potential therapeutic targets of huperzine A for Alzheimer’s disease and vascular dementia. Chem Biol Interact. 2008;175(1–3):396–402. doi:10.1016/j.cbi.2008.04.049
   PubMed Web of Science ®Google Scholar
• Tao LX, Huang X-T, Chen Y-T, et al. Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons. Acta Pharmacol Sin. 2016;37(11):1391–1400. doi:10.1038/aps.2016.78
   PubMed Web of Science ®Google Scholar
• Huang XT, Qian Z-M, He X, et al. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer’s disease. Neurobiol Aging. 2014;35(5):1045–1054. doi:10.1016/j.neurobiolaging.2013.11.004
   PubMed Web of Science ®Google Scholar
• Zorkina Y, Abramova O, Ushakova V, et al. Nano carrier drug delivery systems for the treatment of neuropsychiatric disorders: advantages and limitations. Molecules. 2020;25(22):5294 doi:10.3390/molecules25225294.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xie Y, Tang H, et al. In vitro and in vivo evaluation of a novel estrogen-targeted PEGylated oxaliplatin liposome for gastric cancer. Int J Nanomedicine. 2021;16:8279–8303. doi:10.2147/IJN.S340180
   PubMed Web of Science ®Google Scholar
• Zhao Y-Z, Lin M, Lin Q, et al. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. J Control Release. 2016;224:165–175. doi:10.1016/j.jconrel.2016.01.017
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xin Z, Li N, et al. Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolism. Free Radic Biol Med. 2018;124:1–11. doi:10.1016/j.freeradbiomed.2018.05.082
   PubMed Web of Science ®Google Scholar
• Guo X, Zheng H, Guo Y, et al. Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain. J Nanobiotechnology. 2017;15(1):42. doi:10.1186/s12951-017-0277-2
   PubMedGoogle Scholar
• Kong D, Hong W, Yu M, et al. Multifunctional targeting liposomes of epirubicin plus resveratrol improved therapeutic effect on brain gliomas. Int J Nanomedicine. 2022;17:1087–1110. doi:10.2147/IJN.S346948
   PubMed Web of Science ®Google Scholar
• Amani H, Habibey R, Hajmiresmail SJ, et al. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5(48):9452–9476. doi:10.1039/C7TB01689A
   PubMed Web of Science ®Google Scholar
• Afshari R, Akhavan O, Hamblin MR, et al. Review of oxygenation with nanobubbles: possible treatment for hypoxic COVID-19 patients. ACS Appl Nano Mater. 2021;4(11):11386–11412. doi:10.1021/acsanm.1c01907
   PubMed Web of Science ®Google Scholar
• Wang S, Li W, Sun K, et al. Study of release kinetics and degradation thermodynamics of ferric citrate liposomes. Chem Phys Lipids. 2019;225:104811. doi:10.1016/j.chemphyslip.2019.104811
   PubMed Web of Science ®Google Scholar
• Xiao X, Chen Q, Zhu X, et al. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice. Neurobiol Aging. 2019;81:77–87. doi:10.1016/j.neurobiolaging.2019.05.016
   PubMed Web of Science ®Google Scholar
• Song JX, Zhao Y-S, Zhen Y-Q, et al. Banxia-Houpu decoction diminishes iron toxicity damage in heart induced by chronic intermittent hypoxia. Pharm Biol. 2022;60(1):609–620. doi:10.1080/13880209.2022.2043392
   PubMed Web of Science ®Google Scholar
• Kandzija N, Khutoryanskiy VV. Delivery of riboflavin-5’-monophosphate into the cornea: can liposomes provide any enhancement effects? J Pharm Sci. 2017;106(10):3041–3049. doi:10.1016/j.xphs.2017.05.022
   PubMed Web of Science ®Google Scholar
• Yan Q, Wang W, Weng J, et al. Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer’s disease. Drug Deliv. 2020;27(1):1147–1155. doi:10.1080/10717544.2020.1797240
   PubMed Web of Science ®Google Scholar
• Li F, Hu R, Wang B, et al. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 2017;7(3):353–360. doi:10.1016/j.apsb.2017.02.002
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu C, Zhai W, et al. The optimization design of lactoferrin loaded Hupa nanoemulsion for targeted drug transport via intranasal route. Int J Nanomedicine. 2019;14:9217–9234. doi:10.2147/IJN.S214657
   PubMed Web of Science ®Google Scholar
• Huang Q, Wang P, Liu H, et al. Inhibition of ERK1/2 regulates cognitive function by decreasing expression levels of PSD-95 in the hippocampus of CIH rats. Eur J Neurosci. 2022;55(6):1471–1482. doi:10.1111/ejn.15635
   PubMed Web of Science ®Google Scholar
• Cho KO, Hunt CA, Kennedy MB. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron. 1992;9(5):929–942. doi:10.1016/0896-6273(92)90245-9
   PubMed Web of Science ®Google Scholar
• Tian M, Stroebel D, Piot L, et al. GluN2A and GluN2B NMDA receptors use distinct allosteric routes. Nat Commun. 2021;12(1):4709. doi:10.1038/s41467-021-25058-9
   PubMed Web of Science ®Google Scholar
• Yan L, Jin Y, Pan J, et al. 7,8-dihydroxycoumarin alleviates synaptic loss by activated PI3K-Akt-CREB-BDNF signaling in Alzheimer’s disease model mice. J Agric Food Chem. 2022;70(23):7130–7138. doi:10.1021/acs.jafc.2c02140
   PubMed Web of Science ®Google Scholar
• Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem. 2008;89(3):312–323. doi:10.1016/j.nlm.2007.08.018
   PubMed Web of Science ®Google Scholar
• Xie H, Leung K-L, Chen L, et al. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticity. Neurobiol Dis. 2010;40(1):155–162. doi:10.1016/j.nbd.2010.05.020
   PubMed Web of Science ®Google Scholar
• Flores KR, Viccaro F, Aquilini M, et al. Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients. PLoS One. 2020;15(1):e0227834. doi:10.1371/journal.pone.0227834
   PubMed Web of Science ®Google Scholar
• Xu W, Yao X, Zhao F, et al. Changes in hippocampal plasticity in depression and therapeutic approaches influencing these changes. Neural Plast. 2020;2020:8861903. doi:10.1155/2020/8861903
   PubMed Web of Science ®Google Scholar
• Li L, Yang Y, Zhang H, et al. Salidroside ameliorated intermittent hypoxia-aggravated endothelial barrier disruption and atherosclerosis the cAMP/PKA/RhoA signaling pathway. Front Pharmacol. 2021;12:723922. doi:10.3389/fphar.2021.723922
   PubMed Web of Science ®Google Scholar
• Fei E, Xiong WC, Mei L. Ephrin-B3 recruits PSD-95 to synapses. Nat Neurosci. 2015;18(11):1535–1537. doi:10.1038/nn.4147
   PubMed Web of Science ®Google Scholar
• Wang K, Sun W, Zhang L, et al. Oleanolic acid ameliorates abeta 25-35 Injection-induced memory deficit in Alzheimer’s disease model rats by maintaining synaptic plasticity. CNS Neurol Disord Drug Targets. 2018;17(5):389–399. doi:10.2174/1871527317666180525113109
   PubMed Web of Science ®Google Scholar
• Rispoli V, Ragusa S, Nisticò R, et al. Huperzine a restores cortico-hippocampal functional connectivity after bilateral AMPA lesion of the nucleus basalis of meynert. J Alzheimers Dis. 2013;35(4):833–846. doi:10.3233/JAD-130278
   PubMed Web of Science ®Google Scholar
• Du Y, Liang H, Zhang L, et al. Administration of Huperzine A exerts antidepressant-like activity in a rat model of post-stroke depression. Pharmacol Biochem Behav. 2017;158:32–38. doi:10.1016/j.pbb.2017.06.002
   PubMed Web of Science ®Google Scholar
• Zhao YS, Zhang L-H, Yu -P-P, et al. Ceruloplasmin, a potential therapeutic agent for Alzheimer’s disease. Antioxid Redox Signal. 2018;28(14):1323–1337. doi:10.1089/ars.2016.6883
   PubMed Web of Science ®Google Scholar
• De la fuente-ortega E, Plaza-Briceño W, Vargas-Robert S, et al. Prenatal Ethanol Exposure Misregulates Genes Involved in Iron Homeostasis Promoting a Maladaptation of Iron Dependent Hippocampal Synaptic Transmission and Plasticity. Front Pharmacol. 2019;10:1312. doi:10.3389/fphar.2019.01312
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bai X, Zhang Y, et al. Hippocampal Iron accumulation impairs synapses and memory via suppressing furin expression and downregulating BDNF Maturation. Mol Neurobiol. 2022;59(9):5574–5590. doi:10.1007/s12035-022-02929-w
   PubMed Web of Science ®Google Scholar
• Friedli MJ, Inestrosa NC. Huperzine A and its neuroprotective molecular signaling in Alzheimer’s disease. Molecules. 2021;26(21):6531. doi:10.3390/molecules26216531
   PubMed Web of Science ®Google Scholar
• Atiya A, Alhumaydhi FA, Shamsi A, et al. Mechanistic insight into the binding of huperzine a with human transferrin: computational, spectroscopic and calorimetric approaches. ACS Omega. 2022;7(43):38361–38370. doi:10.1021/acsomega.2c03185
   PubMedGoogle Scholar
• Akhavan O, Hashemi E, Zare H, et al. Influence of heavy nanocrystals on spermatozoa and fertility of mammals. Mater Sci Eng C Mater Biol Appl. 2016;69:52–59. doi:10.1016/j.msec.2016.06.055
   PubMed Web of Science ®Google Scholar
• Akhavan O, Ghaderi E, Hashemi E, Akbari E. Dose-dependent effects of nanoscale graphene oxide on reproduction capability of mammals. Carbon. 2015;95:309–317. doi:10.1016/j.carbon.2015.08.017
   Web of Science ®Google Scholar